GLPG
Price
$27.98
Change
-$0.09 (-0.32%)
Updated
Jun 27 closing price
Capitalization
1.84B
23 days until earnings call
RGNX
Price
$8.39
Change
-$0.36 (-4.11%)
Updated
Jun 27 closing price
Capitalization
422.76M
30 days until earnings call
Interact to see
Advertisement

GLPG vs RGNX

Header iconGLPG vs RGNX Comparison
Open Charts GLPG vs RGNXBanner chart's image
Galapagos
Price$27.98
Change-$0.09 (-0.32%)
Volume$183.09K
Capitalization1.84B
REGENXBIO
Price$8.39
Change-$0.36 (-4.11%)
Volume$1.19M
Capitalization422.76M
GLPG vs RGNX Comparison Chart in %
Loading...
GLPG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLPG vs. RGNX commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLPG is a Buy and RGNX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (GLPG: $27.98 vs. RGNX: $8.39)
Brand notoriety: GLPG and RGNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLPG: 50% vs. RGNX: 105%
Market capitalization -- GLPG: $1.84B vs. RGNX: $422.76M
GLPG [@Biotechnology] is valued at $1.84B. RGNX’s [@Biotechnology] market capitalization is $422.76M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLPG’s FA Score shows that 0 FA rating(s) are green whileRGNX’s FA Score has 1 green FA rating(s).

  • GLPG’s FA Score: 0 green, 5 red.
  • RGNX’s FA Score: 1 green, 4 red.
According to our system of comparison, RGNX is a better buy in the long-term than GLPG.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLPG’s TA Score shows that 5 TA indicator(s) are bullish while RGNX’s TA Score has 4 bullish TA indicator(s).

  • GLPG’s TA Score: 5 bullish, 5 bearish.
  • RGNX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, GLPG is a better buy in the short-term than RGNX.

Price Growth

GLPG (@Biotechnology) experienced а -0.85% price change this week, while RGNX (@Biotechnology) price change was -0.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +31.37%, and the average quarterly price growth was +12.88%.

Reported Earning Dates

GLPG is expected to report earnings on Jul 23, 2025.

RGNX is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLPG($1.84B) has a higher market cap than RGNX($423M). RGNX YTD gains are higher at: 8.538 vs. GLPG (1.745). RGNX (-122.44M) and GLPG (-127.75M) have comparable annual earnings (EBITDA) . GLPG has more cash in the bank: 3.3B vs. RGNX (268M). GLPG has less debt than RGNX: GLPG (10.9M) vs RGNX (79.8M). GLPG has higher revenues than RGNX: GLPG (288M) vs RGNX (157M).
GLPGRGNXGLPG / RGNX
Capitalization1.84B423M436%
EBITDA-127.75M-122.44M104%
Gain YTD1.7458.53820%
P/E Ratio53.70N/A-
Revenue288M157M183%
Total Cash3.3B268M1,230%
Total Debt10.9M79.8M14%
FUNDAMENTALS RATINGS
GLPG vs RGNX: Fundamental Ratings
GLPG
RGNX
OUTLOOK RATING
1..100
1150
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
73
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9196
PRICE GROWTH RATING
1..100
5360
P/E GROWTH RATING
1..100
6521
SEASONALITY SCORE
1..100
508

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RGNX's Valuation (73) in the Biotechnology industry is in the same range as GLPG (74). This means that RGNX’s stock grew similarly to GLPG’s over the last 12 months.

RGNX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as GLPG (100). This means that RGNX’s stock grew similarly to GLPG’s over the last 12 months.

GLPG's SMR Rating (91) in the Biotechnology industry is in the same range as RGNX (96). This means that GLPG’s stock grew similarly to RGNX’s over the last 12 months.

GLPG's Price Growth Rating (53) in the Biotechnology industry is in the same range as RGNX (60). This means that GLPG’s stock grew similarly to RGNX’s over the last 12 months.

RGNX's P/E Growth Rating (21) in the Biotechnology industry is somewhat better than the same rating for GLPG (65). This means that RGNX’s stock grew somewhat faster than GLPG’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GLPGRGNX
RSI
ODDS (%)
Bearish Trend 3 days ago
67%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
51%
Bullish Trend 3 days ago
83%
Momentum
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 3 days ago
87%
MACD
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
87%
Advances
ODDS (%)
Bullish Trend 4 days ago
60%
Bullish Trend 19 days ago
75%
Declines
ODDS (%)
Bearish Trend 24 days ago
78%
Bearish Trend 7 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
61%
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
72%
Bullish Trend 3 days ago
61%
View a ticker or compare two or three
Interact to see
Advertisement
GLPG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SJGAX32.130.29
+0.91%
Steward Large Cap Growth A
AMGIX37.150.12
+0.32%
American Century Discplnd Cor Val I
NPNCX47.770.15
+0.31%
Neuberger Berman Large Cap Value C
CDCRX11.500.03
+0.26%
Copeland Dividend Growth Fund Class C
FFSIX38.940.08
+0.21%
Fidelity Advisor Financials I

GLPG and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLPG has been loosely correlated with VCYT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if GLPG jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLPG
1D Price
Change %
GLPG100%
-0.32%
VCYT - GLPG
43%
Loosely correlated
+2.13%
RGNX - GLPG
37%
Loosely correlated
-4.11%
AXON - GLPG
35%
Loosely correlated
+1.86%
BEAM - GLPG
35%
Loosely correlated
-1.98%
ARWR - GLPG
33%
Loosely correlated
N/A
More

RGNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RGNX has been loosely correlated with DNLI. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if RGNX jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGNX
1D Price
Change %
RGNX100%
-4.11%
DNLI - RGNX
55%
Loosely correlated
-2.69%
ARWR - RGNX
54%
Loosely correlated
N/A
BEAM - RGNX
53%
Loosely correlated
-1.98%
VYGR - RGNX
52%
Loosely correlated
-0.34%
ALEC - RGNX
51%
Loosely correlated
-1.33%
More